Literature DB >> 2854596

Comparison of receptors for Clostridium perfringens type A and cholera enterotoxins in isolated rabbit intestinal brush border membranes.

A P Wnek1, B A McClane.   

Abstract

The rabbit intestinal brush border membrane (BBM) receptors for Clostridium perfringens type A (CPE) and cholera (CT) enterotoxins were compared. Initial studies characterized binding of 125I-CPE to isolated BBMs as specific, saturable, and irreversible. BBMs appear to contain a single type of CPE binding site. Protease pretreatment of BBMs strongly reduced subsequent specific binding of 125I-CPE but not 125I-CT, while neuraminidase pretreatment had little effect on binding of either enterotoxin. Proteases did not significantly release pre-bound 125I-CPE. Preincubation of CPE with an affinity-purified preparation containing a previously identified (Biochem. Biophys. Res. Commun. 112, 1099-105) CPE-binding protein resulted in reduced specific binding of 125I-CPE and an inhibition of CPE biologic activity. Similar experiments showed that CPE-binding protein had no effect on CT binding or biologic activity. Gangliosides had no significant effect on specific binding or biologic activity of CPE but reduced CT binding and biologic activity. Lipids, including gangliosides, separated by thin layer chromatography specifically bound CT but not CPE. Preincubation of BBMs with CT did not reduce subsequent binding of 125I-CPE; conversely, prebound CPE did not affect subsequent 125I-CT binding. These results strongly suggest that CPE does not share the CT BBM receptor ganglioside GM1, and support a role for the CPE-binding protein in CPE binding.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2854596     DOI: 10.1016/0882-4010(86)90035-5

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  9 in total

1.  Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin.

Authors:  Ganes Chakrabarti; Xin Zhou; Bruce A McClane
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

2.  Mapping of functional regions of Clostridium perfringens type A enterotoxin.

Authors:  P C Hanna; E U Wieckowski; T A Mietzner; B A McClane
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

3.  A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice.

Authors:  T A Mietzner; J F Kokai-Kun; P C Hanna; B A McClane
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

4.  Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin.

Authors:  Susan L Robertson; James G Smedley; Bruce A McClane
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

5.  Studies of Clostridium perfringens enterotoxin action at different temperatures demonstrate a correlation between complex formation and cytotoxicity.

Authors:  B A McClane; A P Wnek
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

6.  Preliminary evidence that Clostridium perfringens type A enterotoxin is present in a 160,000-Mr complex in mammalian membranes.

Authors:  A P Wnek; B A McClane
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

7.  Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity.

Authors:  P C Hanna; A P Wnek; B A McClane
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

8.  Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment.

Authors:  E U Wieckowski; J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin.

Authors:  J Katahira; N Inoue; Y Horiguchi; M Matsuda; N Sugimoto
Journal:  J Cell Biol       Date:  1997-03-24       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.